419 related articles for article (PubMed ID: 18664591)
1. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
Thomas RL; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
[TBL] [Abstract][Full Text] [Related]
3. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
Mistry R; Dowling MR; Challiss RA
Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
[TBL] [Abstract][Full Text] [Related]
4. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
[TBL] [Abstract][Full Text] [Related]
5. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
Akam EC; Challiss RA; Nahorski SR
Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
[TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.
Langmead CJ; Austin NE; Branch CL; Brown JT; Buchanan KA; Davies CH; Forbes IT; Fry VA; Hagan JJ; Herdon HJ; Jones GA; Jeggo R; Kew JN; Mazzali A; Melarange R; Patel N; Pardoe J; Randall AD; Roberts C; Roopun A; Starr KR; Teriakidis A; Wood MD; Whittington M; Wu Z; Watson J
Br J Pharmacol; 2008 Jul; 154(5):1104-15. PubMed ID: 18454168
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins.
Michal P; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Feb; 320(2):607-14. PubMed ID: 17065363
[TBL] [Abstract][Full Text] [Related]
10. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
[TBL] [Abstract][Full Text] [Related]
11. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
[TBL] [Abstract][Full Text] [Related]
12. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
[TBL] [Abstract][Full Text] [Related]
13. Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese Hamster ovary cell membranes: 2. Testing the "two-states" model of receptor activation.
Waelbroeck M
Mol Pharmacol; 2001 Apr; 59(4):886-93. PubMed ID: 11259634
[TBL] [Abstract][Full Text] [Related]
14. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
[TBL] [Abstract][Full Text] [Related]
16. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
17. h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
Newman-Tancredi A; Cussac D; Marini L; Touzard M; Millan MJ
Br J Pharmacol; 2003 Mar; 138(6):1077-84. PubMed ID: 12684263
[TBL] [Abstract][Full Text] [Related]
18. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.
Griffin MT; Figueroa KW; Liller S; Ehlert FJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):1193-207. PubMed ID: 17392404
[TBL] [Abstract][Full Text] [Related]
19. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
[TBL] [Abstract][Full Text] [Related]
20. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors.
Olianas MC; Adem A; Karlsson E; Onali P
Eur J Pharmacol; 2004 Mar; 487(1-3):65-72. PubMed ID: 15033377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
